Bundamedik Tbk vs Gunung Raja Paksi Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Gunung Raja Paksi Tbk. trades at Rp296 (market cap 3.56T, 344.8K 24h volume). The key difference: Gunung Raja Paksi Tbk. is far larger — about 2.4× Bundamedik Tbk's market cap, and Bundamedik Tbk is more actively traded (536.7K versus 344.8K). Which is the better fit depends on your goals.
| BMHS | GGRP | |
|---|---|---|
Market Cap | 1.51T | 3.56T |
Volume | 536.7K | 344.8K |
Lot | 5.37K | 3.45K |
Turnover | 93.41M | 101.61M |
Average Price | 174.05 | 294.7 |
Value | 93.41M | 101.61M |
Indicative Equilibrium Price | 176 | 296 |
Indicative Equilibrium Volume | 100 | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →